ScholarIQanswers from OpenAlex

Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study

PaperCitations, authors & open-access status

Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study have?

ScholarIQcitation count

Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study has 24 citations in the OpenAlex counts ScholarIQ stores.

When was Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study published?

ScholarIQyear

Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study has 2011 year in the ScholarIQ index.

What is the open-access status of Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study?

ScholarIQoa status

Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study has closed oa status in the ScholarIQ index.

What is the DOI of Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study?

ScholarIQdoi

The DOI for Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study is on the source record.

What is the PMID of Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study?

ScholarIQpmid

The PMID for Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study is on the source record.

What is the OpenAlex record for Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study?

ScholarIQopenalex

The OpenAlex for Clinical characteristics of patients with drug hypersensitivity in Norway: a single‐centre study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial